Don’t Let PainPut Your Life On Hold
Recognized as a global leader in hyaluronic acid technology, and for always pioneering what’s next, Fidia offers patients much more than pain relief solutions – we offer hope to live better.
Recent Company News
- August 4, 2021Fidia announces the FDA Orphan Drug designation for ONCOFID®-P for the treatment of malignant mesothelioma, the cancer caused by exposure to asbestosMalignant mesothelioma is a rare and aggressive cancer with limited therapeutic options.Read More
- March 30, 2021Fidia Farmaceutici Continues On Its Growth PathFidia signed a binding agreement with Sanofi for the acquisition of a portfolio of anti-inflammatory drugs.Read More
- April 22, 2020COVID-19: to all Fidia Partners, Customers and SuppliersThe health, well-being and safety of the people we engage with, including you, our customers, partners, and suppliers, as well as all of our employees, continues to be a top priority for Fidia.Read More